<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM SCANTEK
MEDICAL, INC. FINANCIAL STATEMENTS AT JUNE 30, 2000 AND THE TWELVE MONTHS THEN
ENDED AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<MULTIPLIER> 1
<S> <C>
<PERIOD-TYPE> 12-MOS
<FISCAL-YEAR-END> JUN-30-2000
<PERIOD-END> JUN-30-2000
<CASH> 2,898
<SECURITIES> 20,735
<RECEIVABLES> 24,000
<ALLOWANCES> 0
<INVENTORY> 721,315
<CURRENT-ASSETS> 777,459
<PP&E> 2,102,059
<DEPRECIATION> 554,053
<TOTAL-ASSETS> 2,426,649
<CURRENT-LIABILITIES> 4,823,899
<BONDS> 0
<COMMON> 18,810
0
0
<OTHER-SE> (5,020,669)
<TOTAL-LIABILITY-AND-EQUITY> 2,426,649
<SALES> 29,775
<TOTAL-REVENUES> 88,775
<CGS> 537,216
<TOTAL-COSTS> 2,523,361
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 417,109
<INCOME-PRETAX> (2,816,465)
<INCOME-TAX> 0
<INCOME-CONTINUING> (2,816,465)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (2,816,465)
<EPS-BASIC> (.15)
<EPS-DILUTED> (.15)
</TABLE>